Article Summary
董鸿 晏昱婧 刘谨文 易继林 沈文状.血清甲状腺过氧化物酶抗体对合并桥本甲状腺炎甲状腺微小癌淋巴结转移影响[J].现代生物医学进展英文版,2015,15(17):3345-3348.
血清甲状腺过氧化物酶抗体对合并桥本甲状腺炎甲状腺微小癌淋巴结转移影响
Effect of SerumTPO-Ab on Lymph Node Metastasis in Papillary ThyroidMicrocarcinoma Combined with Hashimoto's Thyroiditis Patients
  
DOI:
中文关键词: 甲状腺微小乳头状癌  桥本甲状腺炎  血清TPO-Ab 滴度  淋巴结转移
英文关键词: Papillary thyroid microcarcinoma  Hashimoto's thyroiditis  SerumTPO-Ab titer  Lymph node metastasis
基金项目:国家自然科学基金项目(81372204)
Author NameAffiliation
董鸿 晏昱婧 刘谨文 易继林 沈文状 华中科技大学同济医学院附属同济医院 
Hits: 610
Download times: 795
中文摘要:
      目的:探讨合并桥本甲状腺炎的甲状腺微小乳头状癌淋巴结转移的特点,分析血清甲状腺过氧化物酶抗体(Thyroid peroxidase- antibody, TPO-Ab)滴度对该组病例淋巴结转移的影响。方法:回顾性分析武汉同济医院甲状腺乳腺外科2012 年1 月至2014 年5 月收治的甲状腺微小癌伴桥本甲状腺炎的病例,运用卡方检验、阈值效应分析、多因素logistic 回归方法分析该组病例血清 TPO-Ab 滴度对淋巴结转移的影响。结果:共收集75 例合并桥本甲状腺炎的微小乳头状癌病例,血清TPO-Ab 滴度与淋巴结转移 相关:抗体滴度对淋巴结转移的影响存在分段特征,有阈值效应,该组病例以212 IU/mL 为阈值;多因素logistic 回归显示,随着血 清TPO-Ab 水平升高,淋巴结转移率下降(OR=0.993,95%CL=0.987,0.999,P=0.018)。结论:合并桥本甲状腺炎的甲状腺微小乳头 状癌病例,血清TPO-Ab 滴度对淋巴结转移的影响可能存在阈值效应,值得深入分析;且高血清TPO-Ab 滴度可能是淋巴结转移 的保护因素,但两者的相互关系尚需进一步探讨。
英文摘要:
      Objective:To investigate the effect of serumThyroid peroxidase-antibody (TPO-Ab) on cervical lymph node metastasis (CLNM) in papillary thyroid microcarcinoma (PTMC) combined with Hashimoto's Thyroiditis (HT).Methods:A retrospective analysis was performed with patients who were diagnosed as papillary thyroid microcarcinoma combined with Hashimoto's thyroiditis from January 2012 to May 2014 in Wuhan Tongji Hospital. Chi-square test, threshold effect, multivariate Logistic Regression analysis was performed with serum TPO-Ab titer and CLNM. Results:75 cases were collected in our analysis. The preoperative serum TPO-Ab titer was associated with CLNM. Logistic Regression analysis revealed that high TPO-Ab titer corelated with low CLNM rate in these cases (OR=0.993, 95%CL=0.987,0.999, P=0.018).Conclusion:The corelation between serum TPO-Ab and CLNMin PTMC combined with HT may have threshold effect, and high titer may lead to low CLNMrate. But the detail study need to undertake in the future.
View Full Text   View/Add Comment  Download reader
Close